Glaxosmithkline Pharmaceuticals informs about board meeting intimation

28 Jun 2022 Evaluate

Glaxosmithkline Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022, to consider and approve Un- Audited Financial Results for the first quarter ended 30th June 2022.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2065.40 -14.40 (-0.69%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.